Home Cart Sign in  
Chemical Structure| 2165340-32-7 Chemical Structure| 2165340-32-7

Structure of CU-CPT-9a
CAS No.: 2165340-32-7

Chemical Structure| 2165340-32-7
Product Citations

Alternative Products

Product Details of CU-CPT-9a

CAS No. :2165340-32-7
Formula : C17H15NO2
M.W : 265.31
SMILES Code : OC1=CC=C(C2=CC=NC3=CC(OC)=CC=C23)C=C1C
MDL No. :MFCD31689252
InChI Key :HNYBTVKYLVLWCB-UHFFFAOYSA-N
Pubchem ID :135567383

Safety of CU-CPT-9a

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Related Pathways of CU-CPT-9a

pyroptosis
TLR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Bone marrow-derived macrophages (BMDM) 10 μmol/L 1 hour Inhibit TLR8 signaling pathway to evaluate its effect on NET-induced inflammatory cytokine expression PMC9716254

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.77mL

0.75mL

0.38mL

18.85mL

3.77mL

1.88mL

37.69mL

7.54mL

3.77mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories